OraSure Technologies
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (December 2020) |
![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section needs expansion. You can help by adding to it. (July 2020) |
| Nasdaq: OSUR S&P 600 Component | |
| Industry | Medical Devices |
| Headquarters | , |
Area served | Worldwide |
| Products | OraQuick |
OraSure Technologies is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.[1][2][3][4]
History[edit]
OraSure was founded in 1988 by Sam Niedbala, Mike Gausling and two others as SolarCare Technologies Corp.[5]
In 2000, the company merged with Epitope, a company that had developed a way of testing for HIV.[5] After the merger, the company became OraSure.[5]
In 2004, founder Sam Niedbala retired from the company.[5]
In response to the COVID-19 pandemic, OraSure expanded the company by creating over 150 jobs in Bethlehem to work on creating a rapid, at-home coronavirus test.[6] The company had previously developed products to rapidly check for Hepatitis C and Ebola.[6]
Products[edit]
OraSure created the OraQuick test, which can detect the presence of HIV from a mouth swab within 20 minutes.[1] In 2004, the company began marketing OraQuick to health care practitioners.[7]
In a trial by OraSure, the test correctly detected HIV in those carrying the disease 93 percent of the time, a rate below the FDA-recommended 95 percent threshold for accuracy.[7] The test was more accurate at clearing patients who didn't have the disease, correctly identifying HIV-negative users 99 percent of the time.[7]
In July 2012, OraQuick was approved by the Food and Drug Administration for over-the-counter use.[1][2][4]
There is also an OraQuick test for Ebola. The test is a rapid-antigen test that can be used on both live patients and cadavers.[8]
References[edit]
- ^ a b c "FDA approves first take home HIV test kit". The Hindu. 2012-07-04. ISSN 0971-751X. Retrieved 2020-10-09.
- ^ a b McNeil Jr, Donald (2012-07-03). "Rapid H.I.V. Home Test Wins Federal Approval (Published 2012)". The New York Times. ISSN 0362-4331. Retrieved 2020-10-09.
- ^ McNeil Jr, Donald (2012-10-05). "Another Use for Rapid Home H.I.V. Test: Screening Sexual Partners (Published 2012)". The New York Times. ISSN 0362-4331. Retrieved 2020-10-09.
- ^ a b "Home Testing for HIV -- Reading the Lines in Do-It-Yourself Test". ABC News. Retrieved 2020-10-09.
- ^ a b c d Kennedy, Sam (16 May 2004). "Founder trading OraSure for new career, family time ** Sam Niedbala started business with partners in '88. Now, he'll teach". mcall.com. Retrieved 2020-10-09.
- ^ a b Harris, Jon (11 August 2020). "In race for coronavirus test, OraSure to expand, create 177 jobs in Bethlehem as it works to bring 'lab on a swab' to market". The Morning Call. Retrieved 2020-10-09.
- ^ a b c "FDA reviews first rapid, take-home HIV test". khou.com. Retrieved 2020-10-09.
- ^ ""OraQuick Ebola Rapid Antigen Test"". ebola-cases.com.
